BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 363631)

  • 1. A double-blind trial of mazindol using a very low calorie formula diet.
    Baird IM; Howard AN
    Int J Obes; 1977; 1(3):271-8. PubMed ID: 363631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG
    Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of obesity: comparison of physician and nonphysician therapists using placebo and anorectic drugs in a double-blind trial.
    Atkinson RL; Greenway FL; Bray GA; Dahms WT; Molitch ME; Hamilton K; Rodin J
    Int J Obes; 1977; 1(2):113-20. PubMed ID: 363629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative trial on the effects of diet, mazindol, and placebo in the treatment of exogenous obesity (author's transl)].
    Mies R
    Med Klin; 1976 Nov; 71(46):2013-6. PubMed ID: 995040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
    Slama G; Selmi A; Hautecouverture M; Tchobroutsky G
    Diabete Metab; 1978 Sep; 4(3):193-9. PubMed ID: 361463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of mazindol in combined diet therapy consisting of a low-calorie diet and Optifast in severely obese women.
    Yoshida T; Sakane N; Umekawa T; Yoshioka K; Kondo M; Wakabayashi Y
    Int J Clin Pharmacol Res; 1994; 14(4):125-32. PubMed ID: 7607785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of obesity with a very-low-calorie liquid-formula diet: an inpatient/outpatient comparison using skimmed-milk protein as the chief protein source.
    Howard AN; Grant A; Edwards O; Littlewood ER; McLean Baird I
    Int J Obes; 1978; 2(3):321-32. PubMed ID: 721370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term treatment of patients with obesity using mazindol and a reducing diet].
    van Seters AP; Bouwhuis-Hoogerwerf ML; Goslings BM; van Nieuwkoop L; van Slooten H; Struijk-Wielinga T
    Ned Tijdschr Geneeskd; 1982 May; 126(22):990-4. PubMed ID: 7110390
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):816-24. PubMed ID: 813947
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicentre study comparing mazindol and placebo in obese patients.
    Walker BR; Ballard IM; Gold JA
    J Int Med Res; 1977; 5(2):85-90. PubMed ID: 326596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trial with a nonamphetaminic anoretic].
    Campagnoli M
    Rev Iber Endocrinol; 1976; 23(137):463-83. PubMed ID: 794978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-centre trial of mazindol ('Teronac') in general practice in Ireland.
    Evans ER; Wallace MG
    Curr Med Res Opin; 1975; 3(3):132-7. PubMed ID: 1149481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose mianserin as adjuvant therapy in obese patients treated by a very-low-calorie diet.
    Cook RF; Howard AN; Mills IH
    Int J Obes; 1981; 5(3):267-72. PubMed ID: 7024156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the anorectic effect of mazindol and placebo in obesity].
    Tatoń J; Czech A; Koliński P; Podwysocka G
    Pol Tyg Lek; 1979 Dec; 34(50):1967-70. PubMed ID: 395517
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
    Gołebiowska M; Chlebna-Sokół D; Kobierska I; Konopińska A; Małek M; Mastalska A; Zwaigzne-Raczyńska J
    Przegl Lek; 1981; 38(3):355-8. PubMed ID: 7017827
    [No Abstract]   [Full Text] [Related]  

  • 16. A double blind controlled trial of a new anorectic agent AN448.
    Woodhouse SP; Nye ER; Anderson K; Rawlings J
    N Z Med J; 1975 Jun; 81(542):546-9. PubMed ID: 1099491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
    Riesco J; Troncoso G; Costamaillere L; Rodríguez J
    Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
    [No Abstract]   [Full Text] [Related]  

  • 18. Very-low-calorie diet in the treatment of massive obesity: preliminary experience.
    Stokholm KH; Jensen GF; Hansen BB; Quaade F
    Int J Obes; 1980; 4(3):213-20. PubMed ID: 7419339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of simple obesity with mazindol under sanatorium conditions].
    Hasik J; Gawlak E; Tycowa M
    Pol Tyg Lek; 1980 Nov; 35(45):1729-31. PubMed ID: 7012806
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind evaluation of mazindol in refractory obesity.
    Smith RG; Innes JA; Munro JF
    Br Med J; 1975 Aug; 3(5978):284. PubMed ID: 1097046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.